ES2123741T3 - Derivados de bencimidazol, su preparacion y uso. - Google Patents
Derivados de bencimidazol, su preparacion y uso.Info
- Publication number
- ES2123741T3 ES2123741T3 ES94610013T ES94610013T ES2123741T3 ES 2123741 T3 ES2123741 T3 ES 2123741T3 ES 94610013 T ES94610013 T ES 94610013T ES 94610013 T ES94610013 T ES 94610013T ES 2123741 T3 ES2123741 T3 ES 2123741T3
- Authority
- ES
- Spain
- Prior art keywords
- bencimidazole
- derivatives
- preparation
- presented
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/28—Sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/06—Anti-spasmodics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/26—Oxygen atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Pulmonology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
SE PRESENTA UN COMPUESTO QUE TIENE LA FORMULA SIGUIENTE, EN LA QUE X ES O, S; R4, R5, R6 Y R7 SON INDEPENDIENTEMENTE HIDROGENO, HALOGENO O CF3; R1 ES HIDROGENO O NO2; Y ADEMAS SE PRESENTA UN METODO PARA TRATAR UNA ENFERMEDAD DE UN CUERPO DE UN ANIMAL VIVO, INCLUYENDO LOS HUMANOS, QUE ES SENSIBLE A LA ABERTURA DE LOS CANALES DE POTASIO, QUE COMPRENDE LA ADMINISTRACION AL CUERPO DEL ANIMAL VIVO, INCLUYENDO LOS HUMANOS, DE UNA CANTIDAD EFECTIVA DE UN COMPUESTO COMO EL DESCRITO.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK93288A DK28893D0 (da) | 1993-03-15 | 1993-03-15 | Benzimidazole derivater, deres fremstilling og anvendelse |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2123741T3 true ES2123741T3 (es) | 1999-01-16 |
Family
ID=8091872
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES94610013T Expired - Lifetime ES2123741T3 (es) | 1993-03-15 | 1994-03-11 | Derivados de bencimidazol, su preparacion y uso. |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US5475015A (es) |
| EP (1) | EP0617023B1 (es) |
| JP (1) | JP3748901B2 (es) |
| KR (1) | KR100300800B1 (es) |
| AT (1) | ATE172453T1 (es) |
| AU (1) | AU679023B2 (es) |
| CA (1) | CA2118997C (es) |
| DE (1) | DE69414017T2 (es) |
| DK (2) | DK28893D0 (es) |
| ES (1) | ES2123741T3 (es) |
| FI (1) | FI941214L (es) |
| NO (1) | NO304518B1 (es) |
| NZ (1) | NZ260049A (es) |
| ZA (1) | ZA941816B (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW467902B (en) * | 1996-07-31 | 2001-12-11 | Bristol Myers Squibb Co | Diphenyl heterocycles as potassium channel modulators |
| ES2292462T3 (es) * | 1999-08-03 | 2008-03-16 | Abbott Laboratories | Agentes abridores de los canales del potasio. |
| DE10209520A1 (de) * | 2002-03-04 | 2003-09-25 | 4Sc Ag | Neue Modulatoren von Kaliumkanälen |
| WO2004002962A1 (en) * | 2002-06-26 | 2004-01-08 | Poseidon Pharmaceuticals A/S | Novel benzimidazol-2-one derivatives and their use |
| WO2005035498A1 (ja) * | 2003-10-08 | 2005-04-21 | Dainippon Sumitomo Pharma Co., Ltd. | 含窒素二環性化合物の摂食調節剤としての用途 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5200422A (en) * | 1990-09-24 | 1993-04-06 | Neurosearch A/S | Benzimidazole derivatives, their preparation and use |
| NZ239540A (en) * | 1990-09-24 | 1993-11-25 | Neurosearch As | 1-phenyl benzimidazole derivatives and medicaments |
-
1993
- 1993-03-15 DK DK93288A patent/DK28893D0/da not_active Application Discontinuation
-
1994
- 1994-03-02 AU AU56492/94A patent/AU679023B2/en not_active Ceased
- 1994-03-04 US US08/206,506 patent/US5475015A/en not_active Expired - Lifetime
- 1994-03-08 NZ NZ260049A patent/NZ260049A/en not_active IP Right Cessation
- 1994-03-11 EP EP94610013A patent/EP0617023B1/en not_active Expired - Lifetime
- 1994-03-11 DK DK94610013T patent/DK0617023T3/da active
- 1994-03-11 DE DE69414017T patent/DE69414017T2/de not_active Expired - Fee Related
- 1994-03-11 AT AT94610013T patent/ATE172453T1/de not_active IP Right Cessation
- 1994-03-11 ES ES94610013T patent/ES2123741T3/es not_active Expired - Lifetime
- 1994-03-14 JP JP04275094A patent/JP3748901B2/ja not_active Expired - Fee Related
- 1994-03-14 CA CA002118997A patent/CA2118997C/en not_active Expired - Fee Related
- 1994-03-14 NO NO940908A patent/NO304518B1/no unknown
- 1994-03-14 KR KR1019940004982A patent/KR100300800B1/ko not_active Expired - Fee Related
- 1994-03-15 ZA ZA941816A patent/ZA941816B/xx unknown
- 1994-03-15 FI FI941214A patent/FI941214L/fi unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FI941214A7 (fi) | 1994-09-16 |
| DK28893D0 (da) | 1993-03-15 |
| KR100300800B1 (ko) | 2001-11-22 |
| FI941214A0 (fi) | 1994-03-15 |
| NZ260049A (en) | 1996-03-26 |
| AU679023B2 (en) | 1997-06-19 |
| ATE172453T1 (de) | 1998-11-15 |
| DE69414017D1 (de) | 1998-11-26 |
| US5475015A (en) | 1995-12-12 |
| CA2118997A1 (en) | 1994-09-16 |
| NO940908L (no) | 1994-09-16 |
| AU5649294A (en) | 1994-09-22 |
| ZA941816B (en) | 1995-10-13 |
| CA2118997C (en) | 2002-05-28 |
| EP0617023B1 (en) | 1998-10-21 |
| FI941214L (fi) | 1994-09-16 |
| EP0617023A1 (en) | 1994-09-28 |
| DK0617023T3 (da) | 1999-06-28 |
| JP3748901B2 (ja) | 2006-02-22 |
| KR940021534A (ko) | 1994-10-19 |
| NO304518B1 (no) | 1999-01-04 |
| JPH06321910A (ja) | 1994-11-22 |
| DE69414017T2 (de) | 1999-04-08 |
| NO940908D0 (no) | 1994-03-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR010062A1 (es) | Nuevos benzamidaldehidos y su utilizacion | |
| ES2058547T3 (es) | Fuente organica de fluoruro. | |
| ES2167377T3 (es) | Derivados de piridina farmacologicamente activos y procedimientos para la preparacion de los mismos. | |
| ES2170141T3 (es) | 4-aminoderivados del acido micofenolico con actividad inmunosupresora. | |
| AR023727A1 (es) | Compuestos empleados en el tratamiento de padecimientos inflamatorios | |
| DE60033530D1 (de) | Humane antikörper gegen ctla-4 und deren verwendungen | |
| ES2190469T3 (es) | Derivados de isocumarina y su uso en farmacos. | |
| ES2149971T3 (es) | Derivados 5-sustituidos del acido micofenolico. | |
| BR9913932A (pt) | Uso de análogos de glp-1 no tratamento de derrame | |
| TR200002218T2 (tr) | 2-(Pürin-9-il)-Tetrahidrofüran -3,4-Diol türevleri | |
| ES2186015T3 (es) | Derivados de 2-(purin-9-il)-tetrahidrofuran-3,4-diol. | |
| ES2191192T3 (es) | Tienopirimidinas. | |
| CO4290424A1 (es) | Pirazolopiridinas, pirrolopiridinas, composiciones farmaceu- ticas que las contienen y procedimientos para su administra- cion como antagonista del factor de liberacion de cortico- tropina | |
| TR200102977T2 (tr) | Yeni tedavi yöntemi. | |
| ES2192839T3 (es) | Timosina beta 4 oxidada. | |
| ES2084339T3 (es) | Tetrahidropiridinas e hidroxipiperidinas sustituidas utiles como agentes para el sistema nervioso central. | |
| EA200200742A1 (ru) | 1,2-диарилбензимидазолы для лечения заболеваний, связанных с активацией микроглии | |
| SE7902742L (sv) | Disubstituerade 3-cefem-4-karboxylsyraderivat samt forfarande for framstellning derav | |
| HUP0200152A2 (hu) | KQT1 csatornák gátlóinak alkalmazása parazita férgek és ektoparaziták által okozott betegségek kezelésére alkalmas gyógyszerkészítmények előállítására | |
| ATE253904T1 (de) | Verwendung von pharmazeutische zusammensetzungen enthaltend thymol und/oder carvacrol in der behandlung von histomoniasis | |
| TR200100637T2 (tr) | Yeni doğal ürün türevleri | |
| ES2123741T3 (es) | Derivados de bencimidazol, su preparacion y uso. | |
| ES2058282T3 (es) | Derivados de fenol, su produccion y uso. | |
| ES2172558T3 (es) | Lubricante compatible con radiaciones para dispositivos medicos. | |
| AR006084A1 (es) | Aminofeniluracilos substituidos y empleo de los mismos para la lucha contra las plantas indeseables |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 617023 Country of ref document: ES |